Income statement Year ended 2018 Notes Revenue Capital Total 000 000 000 Gains on investments and derivatives at fair value through profit or loss 16 0 55,752 55,752 Income 3 281 0 281 Portfolio management fee 4 0 0 0 Other expenses 5 1,276 0 1,276 Return before finance costs and taxation 995 55,752 54,757 Finance costs 6 2,852 0 2,852 Return before taxation 3,847 55,752 51,905 Taxation 7 0 0 0 Return for the period 3,847 55,752 51,905 Return per ordinary share pence 9 0.47 p 6.74p 6.27p Year ended 2017 Notes Revenue Capital Total 000 000 000 Losses on investments and derivatives at fair value through profit or loss 16 0 12,357 12,357 Income 3 404 0 404 Portfolio management fee 4 0 0 0 Other expenses 5 1,486 0 1,486 Return before finance costs and taxation 1,082 12,357 13,439 Finance costs 6 2,359 0 2,359 Return before taxation 3,441 12,357 15,798 Taxation 7 0 0 0 Return for the period 3,441 12,357 15,798 Return per ordinary share pence 9 0.42 p 1.49 p 1.91 p The notes on pages 66 to 81 form part of these accounts.
The total column of this statement is the profit and loss account of the Company.
All the revenue and capital items in the above statement derive from continuing operations.
There is no other comprehensive income.
62 Woodford Patient Capital Trust plc
